Natural inhibitors of fibrinolysis.
作者信息
Collen D
出版信息
J Clin Pathol Suppl (R Coll Pathol). 1980;14:24-30.
Abstract
摘要
相似文献
1
Natural inhibitors of fibrinolysis.纤维蛋白溶解的天然抑制剂。
J Clin Pathol Suppl (R Coll Pathol). 1980;14:24-30.
2
The fibrinolytic system and its relation to inflammatory diseases.纤维蛋白溶解系统及其与炎症性疾病的关系。
Semin Arthritis Rheum. 1982 May;11(4):390-8. doi: 10.1016/0049-0172(82)90026-9.
3
[Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].[纤维蛋白溶解的分子机制及溶栓治疗的前景]
Vopr Med Khim. 1984 Sep-Oct;30(5):13-22.
4
Interaction of plasminogen activators and inhibitors with plasminogen and fibrin.纤溶酶原激活剂和抑制剂与纤溶酶原及纤维蛋白的相互作用。
Semin Thromb Hemost. 1982 Jan;8(1):2-10. doi: 10.1055/s-2007-1005038.
5
[Blood coagulation mechanism from the viewpoint of molecular biochemistry: Mechanism of fibrinolysis].[从分子生物化学角度看血液凝固机制：纤维蛋白溶解机制]
Rinsho Byori. 1985 Sep;33(9):982-8.
6
[Natural inhibitors of fibrinolysis and their physiological importance].
Usp Fiziol Nauk. 1974 Oct-Dec;5(4):80-95.
7
The pathophysiological role of fibrinolysis inhibitors.
Ric Clin Lab. 1984 Jul-Sep;14(3):499-505. doi: 10.1007/BF02904877.
8
Influence of ethanol and acetaldehyde on fibrinolytic system (examinations in vitro).乙醇和乙醛对纤溶系统的影响（体外实验）
Rocz Akad Med Im Juliana Marchlewskiego Bialymst. 1984;29-30:163-73.
9
Human fibroblasts produce inhibitor directed against plasminogen activator when treated with glucocorticoids.
Ann N Y Acad Sci. 1981;370:609-16. doi: 10.1111/j.1749-6632.1981.tb29767.x.
10
On the regulation and control of fibrinolysis. Edward Kowalski Memorial Lecture.论纤维蛋白溶解的调控。爱德华·科瓦尔斯基纪念讲座。
Thromb Haemost. 1980 Jun 18;43(2):77-89.
引用本文的文献
1
Plant-Derived Compounds and Extracts as Modulators of Plasmin Activity-A Review.植物源化合物和提取物作为纤溶酶活性调节剂的研究进展。
Molecules. 2023 Feb 9;28(4):1677. doi: 10.3390/molecules28041677.
2
Fibrinolysis Shutdown and Hypofibrinolysis Are Not Synonymous Terms: The Clinical Significance of Differentiating Low Fibrinolytic States.纤溶抑制和低纤溶不是同义词：区分低纤溶状态的临床意义。
Semin Thromb Hemost. 2023 Jul;49(5):433-443. doi: 10.1055/s-0042-1758057. Epub 2022 Nov 1.
3
Plasmin inhibition by bacterial serpin: Implications in gum disease.细菌丝氨酸蛋白酶抑制剂对牙龈疾病的影响。
FASEB J. 2020 Jan;34(1):619-630. doi: 10.1096/fj.201901490RR. Epub 2019 Nov 26.
4
Urokinase-type plasminogen activator and its receptor synergize to promote pathogenic proteolysis.尿激酶型纤溶酶原激活剂及其受体协同促进致病性蛋白水解。
EMBO J. 2000 Sep 1;19(17):4817-26. doi: 10.1093/emboj/19.17.4817.
5
Pepsin fibrinolysis of artificial clots made from fibrinogen concentrate and bovine thrombin: the effect of pH and epsilon aminocaproic acid.由纤维蛋白原浓缩物和牛凝血酶制成的人工凝块的胃蛋白酶纤维蛋白溶解作用：pH值和ε-氨基己酸的影响
Surg Endosc. 1989;3(3):148-51. doi: 10.1007/BF00591361.
本文引用的文献
1
The lysis of artificially induced intravascular clots in man by intravenous infusions of streptokinase.通过静脉输注链激酶对人体人工诱导的血管内血栓进行溶解。
J Clin Invest. 1959 Sep;38(9):1627-43. doi: 10.1172/JCI103941.
2
3
ABNORMAL PLASMINOGEN-PLASMIN SYSTEM ACTIVITY (FIBRINOLYSIS) IN PATIENTS WITH HEPATIC CIRRHOSIS: ITS CAUSE AND CONSEQUENCES.肝硬化患者纤溶酶原-纤溶酶系统活性异常（纤维蛋白溶解）：其原因及后果
J Clin Invest. 1964 Apr;43(4):681-95. doi: 10.1172/JCI104953.
4
The existence of antifibrinolysin activity in platelets.血小板中抗纤维蛋白溶解素活性的存在。
Science. 1953 Feb 27;117(3035):229-30.
5
A plasminogen activator in spontaneously active human blood.人自发活性血液中的一种纤溶酶原激活剂。
Proc Soc Exp Biol Med. 1953 Feb;82(2):291-5. doi: 10.3181/00379727-82-20097.
6
Thrombolytic therapy with streptokinase using a standard dosage scheme.采用标准剂量方案的链激酶溶栓治疗。
Br Med J. 1966 Feb 19;1(5485):454-6. doi: 10.1136/bmj.1.5485.454.
7
The purification and properties of human plasminogen.人纤溶酶原的纯化及其性质
Biochem J. 1964 Oct;93(1):171-82. doi: 10.1042/bj0930171.
8
Synthetic inhibitors of fibrinolysis: in vitro and in vivo mode of action.
Ann N Y Acad Sci. 1968 Jun 28;146(2):414-29. doi: 10.1111/j.1749-6632.1968.tb20303.x.
9
Fibrinogenolysis and fibrinolysis with tissue plasminogen activator, urokinase, streptokinase-activated human globulin, and plasmin.
Proc Soc Exp Biol Med. 1971 Oct;138(1):277-80. doi: 10.3181/00379727-138-35878.
10
Factor 13 and antiplasmin activity in human platelets.
Am J Physiol. 1969 Mar;216(3):508-13. doi: 10.1152/ajplegacy.1969.216.3.508.
Zotero 插件